Skip to Main Content

Paper Details

GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity.
Cancer Cell
63
2022
-CAR T cells, CAR, CAR T cell, CARs, GPC2, GPC2 antigen, GPC2-CAR T cells, NB, NBs, Pediatric cancers, T cells, c-Jun, glypican-2, neuroblastoma, oncofetal antigens, solid tumors
Author NameAffiliation
Kristopher R BosseChildren's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania
Alberto DelaidelliBritish Columbia Cancer Research Centre
Scott J Bornheimer
Norman J LacayoStanford University School of Medicine
Jose G Vilches-MoureStanford University School of Medicine
Ansuman T SatpathyStanford University School of Medicine
Howard Y ChangCenter for Personal Dynamic Regulomes, Stanford University, USA Parker Institute for Cancer Immunotherapy, USA Howard Hughes Medical Institute
Sabine Taschner-MandlSt. Anna Children's Cancer Research Institute
Poul H SorensenBritish Columbia Cancer Research Centre
Poul H SorensenBritish Columbia Cancer Research Centre
Dimiter S DimitrovUniversity of Pittsburgh Department of Medicine
John M MarisChildren's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania
John M MarisChildren's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania
  • 1 - 13

Datasets